Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Johnson and Johnson
Harvard Business School
Express Scripts
Moodys

Last Updated: November 29, 2022

CLINICAL TRIALS PROFILE FOR CIALIS


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Cialis

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00050609 ↗ Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying Completed ICOS Corporation Phase 2 2003-02-01 The purposes of this study are to determine whether an experimental drug known as tadalafil can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal, bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population will also be studied.
NCT00050609 ↗ Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying Completed Eli Lilly and Company Phase 2 2003-02-01 The purposes of this study are to determine whether an experimental drug known as tadalafil can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal, bloating, discomfort or pain in the upper abdomen, belching after meals, nausea, vomiting) in diabetic patients, and/or reduce the amount of time the stomach takes to empty the contents of a standard meal. The safety of tadalafil given once daily for 8 weeks in this population will also be studied.
NCT00125918 ↗ PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension Completed ICOS Corporation Phase 3 2005-08-01 The purpose of this study is to evaluate the safety and effectiveness of tadalafil for the treatment of pulmonary arterial hypertension.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cialis

Condition Name

Condition Name for Cialis
Intervention Trials
Erectile Dysfunction 22
Benign Prostatic Hyperplasia 12
Impotence 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cialis
Intervention Trials
Erectile Dysfunction 34
Prostatic Hyperplasia 16
Hyperplasia 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cialis

Trials by Country

Trials by Country for Cialis
Location Trials
United States 173
Canada 30
United Kingdom 18
Germany 15
Italy 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cialis
Location Trials
California 16
Florida 13
Texas 12
Tennessee 10
New York 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cialis

Clinical Trial Phase

Clinical Trial Phase for Cialis
Clinical Trial Phase Trials
Phase 4 25
Phase 3 25
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cialis
Clinical Trial Phase Trials
Completed 70
Unknown status 7
Terminated 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cialis

Sponsor Name

Sponsor Name for Cialis
Sponsor Trials
Eli Lilly and Company 44
ICOS Corporation 18
Cedars-Sinai Medical Center 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cialis
Sponsor Trials
Industry 76
Other 67
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Johnson and Johnson
Baxter
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.